Co-Authors
This is a "connection" page, showing publications co-authored by James Fleming and Zemin Su.
Connection Strength
0.555
-
Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial. Am J Health Syst Pharm. 2021 07 09; 78(14):1287-1293.
Score: 0.198
-
Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study. Clin Transplant. 2020 04; 34(4):e13844.
Score: 0.180
-
Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. Am J Transplant. 2021 10; 21(10):3428-3435.
Score: 0.049
-
Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial. Clin J Am Soc Nephrol. 2021 05 08; 16(5):776-784.
Score: 0.049
-
The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94.
Score: 0.041
-
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938.
Score: 0.038